Trade Marks Journal No: 1865, 03/09/2018 p`kaSana : Baart sarkar vyaapar icanh rijasT/I esa.ema.raoD eMTa^p ihla ko pasa paos
![Pharmaceutics | Free Full-Text | Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic Pharmaceutics | Free Full-Text | Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00530/article_deploy/html/images/pharmaceutics-14-00530-g002.png)
Pharmaceutics | Free Full-Text | Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic
Trade Marks Journal No: 1865, 03/09/2018 p`kaSana : Baart sarkar vyaapar icanh rijasT/I esa.ema.raoD eMTa^p ihla ko pasa paos
Trade Marks Journal No: 1865, 03/09/2018 p`kaSana : Baart sarkar vyaapar icanh rijasT/I esa.ema.raoD eMTa^p ihla ko pasa paos
![Pharmaceutics | Free Full-Text | Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic Pharmaceutics | Free Full-Text | Advances in the Prophylaxis of Respiratory Infections by the Nasal and the Oromucosal Route: Relevance to the Fight with the SARS-CoV-2 Pandemic](https://www.mdpi.com/pharmaceutics/pharmaceutics-14-00530/article_deploy/html/images/pharmaceutics-14-00530-g001.png)